Genetics of variation in serum uric acid and cardiovascular risk factors in Mexican Americans
V Saroja Voruganti1, Subrata D Nath, Shelley A Cole
1Department of Genetics, Southwest Foundation for Biomedical Research, P.O. Box 760549, San Antonio, Texas 78227, USA. svorugan@sfbrgenetics.org
Insights
Serum uric acid levels are significantly heritable in Mexican Americans, with genetic factors influencing its variation. This study identified a key genetic region on chromosome 3p26 linked to serum uric acid and cardiovascular disease risk factors.
Area of Science:
- Genetics
- Cardiovascular Disease Research
- Metabolic Health
Background:
- Elevated serum uric acid is linked to cardiovascular disease (CVD) risk factors like hypertension and obesity.
- The independent role of uric acid in CVD development requires further clarification.
Purpose of the Study:
- To identify quantitative trait loci (QTLs) influencing serum uric acid levels.
- To examine the relationship between serum uric acid and other CVD risk factors in Mexican Americans.
Main Methods:
- Quantitative genetic analysis using variance components decomposition (SOLAR software).
- Genome-wide scan for QTL detection.
- Bivariate analysis to assess correlations between serum uric acid and CVD risk markers.
Main Results:
- Serum uric acid and CVD risk markers demonstrated significant heritability.
- Significant correlations were found between serum uric acid and body mass index, waist circumference, body fat, insulin, triglycerides, HDL cholesterol, and inflammatory markers.
- A significant QTL for serum uric acid variation was identified on chromosome 3p26 (LOD score 4.72), with chemokine receptor 2 as a candidate gene.
Conclusions:
- Serum uric acid levels exhibit a substantial genetic influence on their variation.
- Evidence suggests pleiotropy, where a single gene influences multiple traits, between serum uric acid and cardiovascular risk factors.
Background:
Elevated serum uric acid is associated with several cardiovascular disease (CVD) risk factors such as hypertension, inflammation, endothelial dysfunction, insulin resistance, dyslipidemia, and obesity. However, the role of uric acid as an independent risk factor for CVD is not yet clear.
Objective:
The aim of the study was to localize quantitative trait loci regulating variation in serum uric acid and also establish the relationship between serum uric acid and other CVD risk factors in Mexican Americans (n = 848; men = 310, women = 538) participating in the San Antonio Family Heart Study.
Methods:
Quantitative genetic analysis was conducted using variance components decomposition method, implemented in the software program SOLAR.
Results:
Mean +/- SD of serum uric acid was 5.35 +/- 1.38 mg/dl. Univariate genetic analysis showed serum uric acid and other CVD risk markers to be significantly heritable (P < 0.005). Bivariate analysis showed significant correlation of serum uric acid with body mass index, waist circumference, waist/hip ratio, total body fat, plasma insulin, serum triglycerides, high-density lipoprotein cholesterol, C-reactive protein, and granulocyte macrophage-colony stimulating factor (P < 0.05). A genome-wide scan for detecting quantitative trait loci regulating serum uric acid variation showed a significant logarithm of odds (LOD) score of 4.72 (empirical LOD score = 4.62; P < 0.00001) on chromosome 3p26. One LOD support interval contains 25 genes, of which an interesting candidate gene is chemokine receptor 2.
Summary:
There is a significant genetic component in the variation in serum uric acid and evidence of pleiotropy between serum uric acid and other cardiovascular risk factors.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
